Story Feb. 3 - Omega Therapeutics ... 75% of its employees as it explores strategic alternatives. Story Jan. 22 - Biogen: The neuro-focused biotech is making an undisclosed number of cuts to ...

Omega-3, omega-6, and omega-9 fatty acids provide known health benefits. A supplement may be useful, but these healthy fats ...

Omega-3 fatty acids are essential for maintaining good health, supporting brain function, heart health, and reducing ...

Growing older is unavoidable, but researchers may have found simple ways to slow it down. A recent clinical trial suggests ...

In the first major deal at MIT’s ambitious overhaul of the old Volpe Center in Kendall Square, Cambridge drugmaker Biogen ...

With its move to MIT’s Volpe Center in Kendall Square, the drugmaker is consolidating its local footprint from three buildings to one.

The big biotech signed a 15-year lease for approximately 580,000-square-feet of space in “Kendall Commons,” a development project spearheaded by MIT.

Biogen Inc. plans to move its headquarters into a 16-story Kendall Square tower to be developed by MIT and BioMed Realty ...

Biogen signs lease for Kendall Common as part of multi-year real estate optimization plan to modernize its facilities and consolidate its ...

Fish oil can reduce inflammation and lower cardiovascular disease risk. Yet a growing body of research suggests that ...

After months of debate about the validity of its phase 3 clinical trials for Alzheimer's therapy Aduhelm, Biogen has published the results in a peer-review journal, allowing physicians to look at ...

UCB and Biogen say their first phase 3 trial of their systemic lupus erythematosus (SLE) candidate dapirolizumab pegol was a success, and a second is now expected to start before the end of the year.